Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
5MED is a French medical technology company that specializes in the design, development, and manufacture of surgical implants for urology and gynecology. Founded in 2008 and based in Gap, France, the company focuses on providing innovative solutions for pelvic floor disorders, including female stress urinary incontinence and pelvic organ prolapse. Its product portfolio features high-quality synthetic meshes and sub-urethral slings, such as the Swing and MRS systems, which are designed for minimally invasive surgical procedures. The company emphasizes high manufacturing standards and holds ISO 13485 certification for its production processes. In 2019, 5MED was acquired by Promedon, a global leader in the urological and urogynecological fields, to enhance its product offerings and expand its international reach. Today, 5MED operates as a key subsidiary within the Promedon group, continuing to serve the European and global markets with specialized surgical implants.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 5med.